Dato' Dr. Colin Lee Soon Soo

About

Dato’ Dr. Colin Lee Soon Soo is the founder and Medical Director of Alpha IVF & Women’s Specialists (previously Alpha Fertility Centre), which he established in 2011 in Kota Damansara, Selangor. He qualified as a Consultant Obstetrician and Gynaecologist in 1991 after earning his medical degree at the University of New South Wales, Australia (1982) and his specialist qualification from the Royal College of Obstetricians and Gynaecologists (FRCOG), United Kingdom.

Under his leadership, the centre’s doctors and embryologists have recorded more than 20 world-first fertility achievements — including the world’s first successful pregnancy and delivery in a woman born without a vagina (Mullerian dysgenesis, 2012) and the world’s first healthy baby born after PGT for a couple carrying mutations in the TBCD gene (2024). In March 2024 he led Alpha IVF onto the ACE Market of Bursa Malaysia (stock code 0303), making it the country’s first publicly listed fertility specialty group.

Clinical Expertise

• Complex case consultation and treatment strategy: as the group’s senior clinical decision-maker, he focuses on repeated IVF failure, difficult diagnoses and cross-disciplinary case design rather than routine cycle work
• Genetics-led reproduction: his team’s breakthroughs in PGT — the TBCD double-mutation case, chromosome inversion and translocation diagnosis by CGH, and single-biopsy PGT-M plus HLA typing for Saviour Sibling Programmes — reflect a deep specialisation in embryo screening strategy
• Full-spectrum assisted reproduction: IVF, ICSI, PGT-A/PGT-M, egg freezing, egg donation and fertility preservation, with early adoption of Piezo-ICSI, AI embryo selection and time-lapse culture as centre standards
• Clinical quality governance: he steers the centre’s RTAC accreditation (Fertility Society of Australia) and MHTC Elite membership, and sets laboratory and care protocols across the group’s Malaysian, Singapore, Indonesian, Chinese and Philippine operations

Why Choose Dato’ Dr. Colin Lee

Choosing Dr. Colin Lee means direct access to the clinician who sets quality standards for the entire Alpha IVF group. He combines over 30 years of obstetrics and gynaecology practice with a documented research record — his group’s data on vitrified-warmed euploid blastocysts was presented at the 24th Congress of the Obstetrical and Gynaecological Society of Malaysia in 2016 — so treatment recommendations are grounded in the centre’s own published outcomes.

His track record of world-firsts signals willingness and technical capacity to take on cases other centres turn away, from extreme genetic risk to anatomically complex infertility. And because Alpha IVF operates as a listed company, patients benefit from audited governance, transparent processes and long-term institutional stability — an important consideration for international patients committing to a multi-visit treatment plan.

Certifications

• Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG), United Kingdom (1991)
• MBBS, University of New South Wales, Australia (1982)
• Master of Medicine (MMed), National University of Singapore
• Medical Director of an RTAC-accredited ART unit (RTAC Number 1028); listed company founder and director, Bursa Malaysia ACE Market (code 0303)

Suitable For

• Patients with repeated IVF failure: Dr. Colin Lee re-examines the full diagnostic picture — stimulation response, embryo development data, endometrial factors — and rebuilds the treatment strategy from first principles
• Families with hereditary disease risk: couples needing PGT-A or PGT-M for chromosomal rearrangements or single-gene disorders sit at the centre of his group’s published expertise, including concurrent testing from a single biopsy
• Cases needing combined surgical and fertility planning: patients with uterine or gynaecological abnormalities can have reproduction and surgical pathways designed together within one group
• International patients prioritising stability: those choosing a clinic for governance quality and continuity — a listed, RTAC-accredited group with multilingual (English, Mandarin, Malay) coordination — will find his founding-team led care a strong assurance